Literature DB >> 4087006

Bethanechol decreases reaction time in senile dementia of the Alzheimer type.

P Davous, Y Lamour.   

Abstract

Bethanechol, a muscarinic cholinergic agonist, was injected subcutaneously in eight cases of senile dementia of the Alzheimer type. Simple reaction time was measured before, 15 min and 30 min following the injection. Before injection, the patients had significantly longer reaction time than non-demented controls. A significant shortening of the reaction time was observed 15 min but not 30 min after injection. A second group of eight patients with senile dementia of the Alzheimer type, matched for age and mental impairment were injected with saline. No significant shortening of the reaction time was observed. These results suggest that the reaction time can be shortened by a muscarinic agonist in dementia of the Alzheimer type.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087006      PMCID: PMC1028618          DOI: 10.1136/jnnp.48.12.1297

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

2.  Brief objective measures for the determination of mental status in the aged.

Authors:  R L KAHN; A I GOLDFARB; M POLLACK; A PECK
Journal:  Am J Psychiatry       Date:  1960-10       Impact factor: 18.112

3.  Reaction time as a diagnostic measure in senility.

Authors:  S Ferris; T Crook; G Sathananthan; S Gershon
Journal:  J Am Geriatr Soc       Date:  1976-12       Impact factor: 5.562

4.  The cholinergic pharmacology of hippocampal pyramidal cells: a microiontophoretic study.

Authors:  S J Bird; G K Aghajanian
Journal:  Neuropharmacology       Date:  1976-05       Impact factor: 5.250

5.  Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.

Authors:  R E Harbaugh; D W Roberts; D W Coombs; R L Saunders; T M Reeder
Journal:  Neurosurgery       Date:  1984-10       Impact factor: 4.654

6.  Reaction time in Parkinson's disease.

Authors:  E V Evarts; H Teräväinen; D B Calne
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

Review 7.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

8.  Excitatory effect of acetylcholine on different types of neurons in the first somatosensory neocortex of the rat: laminar distribution and pharmacological characteristics.

Authors:  Y Lamour; P Dutar; A Jobert
Journal:  Neuroscience       Date:  1982-06       Impact factor: 3.590

Review 9.  Measurement of cholinergic drug effects on memory in Alzheimer's disease.

Authors:  S D Brinkman; S Gershon
Journal:  Neurobiol Aging       Date:  1983       Impact factor: 4.673

  9 in total
  3 in total

Review 1.  Neurotransmitter replacement therapy in Alzheimer's disease.

Authors:  E Mohr; T Mendis; I N Rusk; J D Grimes
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

2.  A comparative evaluation of the short orientation memory concentration test of cognitive impairment.

Authors:  P Davous; Y Lamour; E Debrand; P Rondot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

3.  Clinical and Preclinical Cognitive Function Improvement after Oral Treatment of a Botanical Composition Composed of Extracts from Scutellaria baicalensis and Acacia catechu.

Authors:  Mesfin Yimam; Bruce P Burnett; Lidia Brownell; Qi Jia
Journal:  Behav Neurol       Date:  2016-11-30       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.